4-Hydroxystyrene



Compound IDCDAMM00011
Common name4-Hydroxystyrene
IUPAC name4-ethenylphenol
Molecular formulaC8H8O

Experimental data

Retention time9.99
Adduct[M+H]+
Actual mz121.064
Theoretical mz121.065
Error4.87
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7875

Identifiers and class information

Inchi keyFUGYGGDSWSUORM-UHFFFAOYSA-N
SmilesC=CC1=CC=C(C=C1)O
SuperclassBenzenoids
ClassBenzene and substituted derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)2
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)1
Molecular weight (mol_MW)120.151
Computed dipole moment(dipole)1.472
Total solvent accessible surface area (SASA)329.225
Hydrophobic component of SASA (FOSA)64.699
Hydrophilic component of SASA (FISA)54.627
Pie component of the SASA (PISA)209.9
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)499.195
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)0.75
Free energy of solvation of dipole (dip^2/V)0.0043395
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0022781
Globularity descriptor (glob)0.924383
Predicted polarizability in cubic angstroms (QPpolrz)14.544
Predicted hexadecane/gas partition coefficient (QPlogPC16)5
Predicted octanol/gas partition coefficient (QPlogPoct)5.985
Predicted water/gas partition coefficient (QPlogPw)4.073
Predicted octanol/water partition coefficient (QPlogPo/w)2.199
Predicted aqueous solubility (QPlogS)-1.122
Conformation-independent predicted aqueous solubility (CIQPlogS)-1.583
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.757
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)3005.22
Predicted brain/blood partition coefficient (QPlogBB)0.017
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1625.09
Predicted skin permeability, log Kp (QPlogKp)-1.595
PM3 calculated ionization potential (IP(ev))8.808
PM3 calculated electron affinity (EA(eV))0.086
Number of likely metabolic reactions (#metab)1
Prediction of binding to human serum albumin (QPlogKhsa)-0.304
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)22.544
Number of nitrogen and oxygen atoms (#NandO)1
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P02766TTRTransthyretinT86462SEA
P05067APPBeta amyloid A4 proteinT87024SEA
P16083NQO2Quinone reductase 2T75498SEA
P43166CA7Carbonic anhydrase VIIT37541SEA
P23280CA6Carbonic anhydrase VIT06569SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P80404ABATGamma-amino-N-butyrate transaminaseT59045SEA
Q92731ESR2Estrogen receptor betaT80896SEA
P03372ESR1Estrogen receptor alphaT02506SEA
Q9GZQ4NMUR2Neuromedin-U receptor 2T04210SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P62508ESRRGEstrogen-related receptor gammaT59875SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
P51649ALDH5A1Succinate semialdehyde dehydrogenaseT13259SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T86462DI0026Amyloidosis[ICD-11: 5D00]P02766TTR
T87024DI0025Alzheimer disease[ICD-11: 8A20]P05067APP
T87024DI0122Diagnostic imaging[ICD-11: N.A.]P05067APP
T75498DI0214Insomnia[ICD-11: 7A00-7A0Z]P16083NQO2
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T59045DI0060Brain cancer[ICD-11: 2A00]P80404ABAT
T59045DI0134Epilepsy/seizure[ICD-11: 8A61-8A6Z]P80404ABAT
T59045DI0135Epileptic encephalopathy[ICD-11: 8A62]P80404ABAT
T59045DI0266Mineral deficiency[ICD-11: 5B5K]P80404ABAT
T59045DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P80404ABAT
T80896DI0062Breast cancer[ICD-11: 2C60-2C6Y]Q92731ESR2
T80896DI0108Cushing syndrome[ICD-11: 5A70]Q92731ESR2
T80896DI0254Menopausal disorder[ICD-11: GA30]Q92731ESR2
T80896DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q92731ESR2
T02506DI0106COVID-19[ICD-11: 1D6Y]P03372ESR1
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T13259DI0122Diagnostic imaging[ICD-11: N.A.]P51649ALDH5A1
T13259DI0306Nutritional deficiency[ICD-11: 5B50-5B71]P51649ALDH5A1

Copyright © 2025